Umpierrez, G., Tof Povedano, S., Prez Manghi, F., Shurzinske, L
doi: 10.1016/j.freeradbiomed.2022.04.011 101 FutagamiSHiratsukaTShindoTHorieAHamamotoTSuzukiKet al
In the long run, this leads to improved health and improved healthspan
Statins inhibit hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, a key enzyme in cholesterol synthesis in hepatocytes, resulting in increased LDL receptor activity on these cells and increased clearance of lipoproteins containing apolipoprotein B-100, i.e., LDL and VLDL remnants (including intermediate density lipoprotein IDL) [35, 50]
These processes were attenuated by mono- and combination therapy, with aCD3 mostly restoring beta cell identity and GLP1-E2 reducing beta cell stress and immunogenicity
14 Liraglutide and semaglutide, originally developed for people with Type 2 diabetes mellitus (T2DM), are approved for chronic weight management in people with obesity (or overweight and 1 weight-related comorbidities